Full Press Release Details
PHILADELPHIA, April 3, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that it will present at the following upcoming conferences:
Needham 23rd Annual Virtual Healthcare Conference
Steven Kelly, President and Chief Executive Officer, will give a corporate presentation.
Wednesday, April 10 at 3:45 PM ET
Chardan 8th Annual Genetic Medicines & Cell Therapy Manufacturing Summit
Steven Kelly, President and Chief Executive Officer, will give a corporate presentation.
Monday, April 29 at 2:00 PM ET
Live webcasts will be available on the Company's Investor Events webpage. A replay of the webcasts, when available, will be archived for a limited time following each event.
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.
Head of Investor Relations
SOURCE Carisma Therapeutics Inc.
21 %
more press release views with